Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
30m agoMarsh Risk unveils AI-powered Risk Companion suite of analytics to empower clients with faster, smarter risk management
31m agoMissouri American Water Proudly Recognizes American Water Charitable Foundation 2026 Water and Environment Grantees
31m agoProtein Alternatives Market Research Report 2026 with Analyst Recommendations and Global Forecast to 2031 Featuring ADM, Beyond Meat, Kerry, Ingredion, Axiom Foods, Impossible Foods, and Cargill
32m agoResolutions by Lassila & Tikanoja Plc’s Annual General Meeting and the constitutive meeting of the Board of Directors
51m agoXTM Commences Court-Approved Sale and Investment Solicitation Process with Stalking Horse Bid
Aim Immunotech Inc. logo

Aim Immunotech Inc.

About

Aim Immunotech Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 13 2026
AIM ImmunoTech Provides Routine Update on Annual Filings
Apr 9 2026
AIM ImmunoTech to Participate in Live Virtual Investor Closing Bell Event
Apr 1 2026
AIMIA PROVIDES UPDATE ON ITS SHARE BUYBACKS
Mar 24 2026
AIMIA REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS
Mar 18 2026
AIM ImmunoTech Announces Final Approval of Novel Cancer Therapy Patent in Japan Combining Ampligen with Checkpoint Inhibitors

Community Chat

Ask AI

6ix6ix